20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with gsk0660 in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (gsk0660) | Trials (gsk0660) | Recent Studies (post-2010) (gsk0660) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 55 | 0 | 45 |
| Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | gsk0660 (IC50) |
|---|---|---|---|
| Peroxisome proliferator-activated receptor delta | Mus musculus (house mouse) | 0.048 | |
| Peroxisome proliferator-activated receptor delta | Homo sapiens (human) | 0.2099 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Cheng, O; Ding, S; Huang, B; Huang, J; Jiang, Q; Qiu, H; Zhang, J | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and gsk0660
| Article | Year |
|---|---|
Effects of PPARs/20-HETE on the renal impairment under diabetic conditions.
Topics: Amidines; Anilides; Animals; Cell Line; Cytochrome P-450 CYP4A; Diabetic Nephropathies; Down-Regulation; Epithelial Cells; Gene Expression Regulation; Glucose; Hydroxyeicosatetraenoic Acids; Indoles; Kidney Tubules; Male; Mice; PPAR alpha; PPAR gamma; PPAR-beta; Rats; Sulfones; Thiophenes | 2019 |